Correlation Between Sysco and Canopus BioPharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Sysco and Canopus BioPharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sysco and Canopus BioPharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sysco and Canopus BioPharma Incorporated, you can compare the effects of market volatilities on Sysco and Canopus BioPharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sysco with a short position of Canopus BioPharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sysco and Canopus BioPharma.

Diversification Opportunities for Sysco and Canopus BioPharma

0.09
  Correlation Coefficient

Significant diversification

The 3 months correlation between Sysco and Canopus is 0.09. Overlapping area represents the amount of risk that can be diversified away by holding Sysco and Canopus BioPharma Incorporated in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Canopus BioPharma and Sysco is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sysco are associated (or correlated) with Canopus BioPharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Canopus BioPharma has no effect on the direction of Sysco i.e., Sysco and Canopus BioPharma go up and down completely randomly.

Pair Corralation between Sysco and Canopus BioPharma

Considering the 90-day investment horizon Sysco is expected to generate 33.7 times less return on investment than Canopus BioPharma. But when comparing it to its historical volatility, Sysco is 26.58 times less risky than Canopus BioPharma. It trades about 0.08 of its potential returns per unit of risk. Canopus BioPharma Incorporated is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest  0.01  in Canopus BioPharma Incorporated on October 30, 2024 and sell it today you would earn a total of  0.00  from holding Canopus BioPharma Incorporated or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy94.74%
ValuesDaily Returns

Sysco  vs.  Canopus BioPharma Incorporated

 Performance 
       Timeline  
Sysco 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Sysco are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of fairly strong basic indicators, Sysco is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.
Canopus BioPharma 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Canopus BioPharma Incorporated are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. Despite somewhat uncertain forward indicators, Canopus BioPharma sustained solid returns over the last few months and may actually be approaching a breakup point.

Sysco and Canopus BioPharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Sysco and Canopus BioPharma

The main advantage of trading using opposite Sysco and Canopus BioPharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sysco position performs unexpectedly, Canopus BioPharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Canopus BioPharma will offset losses from the drop in Canopus BioPharma's long position.
The idea behind Sysco and Canopus BioPharma Incorporated pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.

Other Complementary Tools

Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets